Blake Wise, Novome CEO
November 10, 2021 09:25 AM ESTUpdated November 12, 09:23 PM
Deals

Genen­tech teams with lit­tle Novome on IBD re­search, look­ing to col­o­nized bac­te­ria af­ter a se­vere set­back

John Carroll

Editor & Founder

Back at the be­gin­ning of 2020, Genen­tech vet Blake Wise jumped to a start­up in the Bay Area called Novome, join­ing at the same time …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times